Alfredo Berruti
Publications by Year
Research Areas
Adrenal and Paraganglionic Tumors, Cancer, Hypoxia, and Metabolism, Pituitary Gland Disorders and Treatments, Glioma Diagnosis and Treatment, Hormonal Regulation and Hypertension
Most-Cited Works
- → Combination Chemotherapy in Advanced Adrenocortical Carcinoma(2012)853 cited
- → Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up(2012)327 cited
- → Plasma Concentrations of o,p′DDD, o,p′DDA, and o,p′DDE as Predictors of Tumor Response to Mitotane in Adrenocortical Carcinoma: Results of a Retrospective ENS@T Multicenter Study(2011)172 cited
- → Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study(2010)162 cited
- → Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma(2011)134 cited
- → Multimodal management of stages III–IVa malignant thymoma(2003)120 cited
- → Low-Dose Monitored Mitotane Treatment Achieves the Therapeutic Range with Manageable Side Effects in Patients with Adrenocortical Cancer1(2000)116 cited
- → Rare Cancers Europe (RCE) methodological recommendations for clinical studies in rare cancers: a European consensus position paper(2014)114 cited
- → Adjuvant Therapy in Patients With Adrenocortical Carcinoma: A Position of an International Panel(2010)104 cited
- → Metronomic chemotherapy may be active in heavily pre-treated patients with metastatic adreno-cortical carcinoma.(2013)15 cited